"biotechs require much more stringent for obvious reasons - to meet guidelines and regulations"
Hasn't prevented Alnylam from attaining an @ $2billion market cap. Their efficiency and durabilty is questionable to say the least.
- Forums
- ASX - By Stock
- BLT
- capital raising !
capital raising !, page-83
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online